CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,030,805
- in 10 filings, $173K under 10b5-1 plans
Net −$1,030,805. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-22 | Stout Jay S Chief Technology Officer | Sale | −2,520 | $19.03 | $48K | 200,814 |
| 2025-10-08 | Geffner Michael Chief Medical Officer | Sale | −1,272 | $16.30 | $21K | 220,553 |
| 2025-10-08 | Stout Jay S Chief Technology Officer | Sale | −1,585 | $16.30 | $26K | 203,334 |
| 2025-07-28 | Venker Eric Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,300,000 | 1,300,000 | ||
| 2025-07-28 | Venker Eric Chief Executive Officer | Grant or award · Stock Option (right to buy) | +189,900 | 189,900 | ||
| 2025-07-28 | Venker Eric Chief Executive Officer | Grant or award · Capped Value Appreciation Rights | +1,475,000 | 1,475,000 | ||
| 2025-07-23 | Stout Jay S Chief Technology Officer | Sale | −2,805 | $18.15 | $51K | 204,919 |
| 2025-07-23 | Geffner Michael Chief Medical Officer | Sale | −2,385 | $18.15 | $43K | 221,825 |
| 2025-07-09 | Geffner Michael Chief Medical Officer | Sale | −1,160 | $17.24 | $20K | 224,210 |
| 2025-07-09 | Stout Jay S Chief Technology Officer | Sale | −1,519 | $17.24 | $26K | 207,724 |
| 2025-05-01 | Girao Tiago Chief Financial Officer | Grant or award | +208,388 | 208,388 | ||
| 2025-05-01 | Girao Tiago Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +293,505 | 293,505 | ||
| 2025-05-01 | Bauer Jake Director | Grant or award | +25,016 | 25,016 | ||
| 2025-05-01 | Bauer Jake Director | Grant or award · Stock Option (Right to Buy) | +35,234 | 35,234 | ||
| 2025-05-01 | Susman Robert Graham Director | Grant or award | +25,016 | 25,016 | ||
| 2025-05-01 | Susman Robert Graham Director | Grant or award · Stock Option (Right to Buy) | +35,234 | 35,234 | ||
| 2025-04-23 | Stout Jay S Chief Technology Officer | Sale | −1,925 | $14.79 | $28K | 209,243 |
| 2025-04-23 | Geffner Michael Chief Medical Officer | Sale | −2,349 | $14.79 | $35K | 225,370 |
| 2025-04-16 | Barnett Eva Renee Chief Financial Officer | Sale | −2,993 | $14.89 | $45K | 396,774 |
| 2025-04-16 | Salzmann Peter Chief Executive Officer | Sale | −8,321 | $14.89 | $124K | 1,178,191 |
Page 7 of 10 · 191 trades